Patents by Inventor Bing Xiong

Bing Xiong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12001577
    Abstract: A machine learning model, such as a neural network, is partially encrypted with a homomorphic encryption scheme. Application of the machine learning model to data includes performing operations on plaintext and encrypting results of operations for input to other operations that are performed over cyphertext. Ciphertext output of such operations can be provided to a service that is able to decrypt the ciphertext output.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: June 4, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Yuanjun Xiong, Jia Bi Zhang, Bing Shuai, Juan Pablo Escalona Garcia
  • Patent number: 11967055
    Abstract: Technology for inspection for detecting a defect of a printed matter using machine logic informed by machine learning. Some embodiments of the present invention may include one, or more, of the following features: (i) generates defect datasets; (ii) generates defect libraries; (iii) uses the generated defect libraries for deep learning training; and (iv) uses machine learning to detect defects using computer code (for example, a *.jpg format file) corresponding to an image of a piece of printed matter instead of using a visual image (that is, an image of the type that is created when a person takes a picture using a traditional film camera).
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: April 23, 2024
    Assignee: International Business Machines Corporation
    Inventors: Zhuo Cai, Chao Xin, Dan Zhang, Hong Bing Zhang, De Bo Xiong
  • Patent number: 11964376
    Abstract: A multi-function handheld electric tool includes a motor housing receiving a motor, a settable clutch coupled with a speed reduction transmission, transmission housing coupled to the motor housing and having a first housing portion coupled to the motor housing, and a second housing portion extending from the first portion towards a chuck, and a setting collar which is rotatably fit over the second housing portion of the transmission housing and rotatable between a plurality of predetermined angular positions of which at least one corresponds to a non-torque limited first operation mode of the tool and the remaining positions correspond to different torque output levels of a torque limited second operation mode of the tool.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: April 23, 2024
    Assignee: Techtronic Cordless GP
    Inventors: Guo Hui Xiong, Wei Bing Wang
  • Patent number: 11958789
    Abstract: A method for determining a consistency coefficient of a power-law cement grout includes: determining a water-cement ratio of the power-law cement grout; according to engineering practice requirements, determining a time required to determine the consistency coefficient of the power-law cement grout; and obtaining the consistency coefficient of the power-law cement grout. The method is accurate and reliable, requires less calculation, etc.; and has very high practical value and popularization value in environmental protection and ecological restoration.
    Type: Grant
    Filed: December 12, 2023
    Date of Patent: April 16, 2024
    Assignee: KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Zhi-quan Yang, Jun-fan Xiong, Ying-yan Zhu, Yi Yang, Yong-shun Han, Muhammad Asif Khan, Jian-bin Xie, Tian-bing Xiang, Bi-hua Zhang, Han-hua Xu, Jie Zhang, Shen-zhang Liu, Qi-jun Jia, Cheng-yin Ye, Gang Li
  • Patent number: 11946845
    Abstract: A method for determining a three-dimensional tortuosity of a loose and broken rock-soil mass, includes the following steps: a particle grading curve of the loose and broken rock-soil mass is obtained by utilizing a particle size analysis, and followed by calculating an equivalent particle size and an average particle size; a porosity of the loose and broken rock-soil mass is obtained by utilizing a moisture content test, a density test, and a specific gravity test; the three-dimensional tortuosity of the loose and broken rock-soil mass is obtained by utilizing the equivalent particle size, the average particle size and the porosity of the loose and broken rock-soil mass. The method has the advantages of simple logic, accuracy and reliability, simple and fast parameter determination, and has high practical value and promotion value in the field of environmental protection and ecological restoration technology.
    Type: Grant
    Filed: November 1, 2023
    Date of Patent: April 2, 2024
    Assignee: KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Zhi-quan Yang, Jia-jun Zhang, Jun-fan Xiong, Ying-yan Zhu, Yi Yang, Muhammad Asif Khan, Tian-bing Xiang, Bi-hua Zhang, Han-hua Xu, Jie Zhang, Shen-zhang Liu
  • Patent number: 11655239
    Abstract: The present disclosure relates to a fused ring pyrimidine amino compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically disclosed in the present disclosure are the compound shown in formula I, a pharmaceutically acceptable salt thereof, a tautomer thereof, a stereoisomer thereof, a metabolite thereof, a metabolic precursor thereof, or a prodrug thereof. The fused ring pyrimidine amino compound of the present application has good inhibitory activity against DDRs, particularly DDR2, and has a good therapeutic effect on tumors and fibrotic diseases, especially pulmonary inflammation and pulmonary fibrosis. Also disclosed in the present disclosure are a preparation method for the compound shown in formula I, and a use thereof.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: May 23, 2023
    Assignee: Shanghai Institute Of Material Medica, Chinese Academy of Sciences
    Inventors: Bing Xiong, Jia Li, Meiyu Geng, Jingkang Shen, Yi Zang, Jing Ai, Danqi Chen, Qi Wang, Ying Dong, Xia Peng, Yinchun Ji, Qian Tan
  • Publication number: 20220274962
    Abstract: The present disclosure relates to a fused ring pyrimidine amino compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically disclosed in the present disclosure are the compound shown in formula I, a pharmaceutically acceptable salt thereof, a tautomer thereof, a stereoisomer thereof, a metabolite thereof, a metabolic precursor thereof, or a prodrug thereof. The fused ring pyrimidine amino compound of the present application has good inhibitory activity against DDRs, particularly DDR2, and has a good therapeutic effect on tumors and fibrotic diseases, especially pulmonary inflammation and pulmonary fibrosis. Also disclosed in the present disclosure are a preparation method for the compound shown in formula I, and a use thereof.
    Type: Application
    Filed: July 17, 2020
    Publication date: September 1, 2022
    Inventors: Bing XIONG, Jia LI, Meiyu GENG, Jingkang SHEN, Yi ZANG, Jing AI, Danqi CHEN, Qi WANG, Ying DONG, Xia PENG, Yinchun JI, Qian TAN
  • Patent number: 11078188
    Abstract: The present invention relates to dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof. The inhibitor of the present invention is compound represented by general formula (I), or stereoisomer, pharmaceutically acceptable salt, prodrug, solvate, hydrate and crystal form thereof. The definition of each substituent is as described in the description and claims. The compound represented by general formula (I) of the present invention may inhibit bromodomain recognition protein and may be used for preparing medicament which regulates the apparent state of cells and treats series of diseases and symptoms which are mediated by the bromodomain recognition protein.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 3, 2021
    Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Bing Xiong, Jingkang Shen, Zehong Miao, Jianping Hu, Yingqing Wang, Shanshan Song, Tao Meng
  • Patent number: 10670464
    Abstract: A method of collecting radiation information of a turbine blade, the method including: 1) collecting a radiated light from the surface of the turbine blade, analyzing the radiated light using a spectrometer to calculate compositions and corresponding concentrations of combustion gas; 2) calculating an absorption coefficient of the combustion gas at different concentrations; 3) calculating a total absorption rate of the combustion gas at different radiation wavelengths under different concentrations of component gases; 4) obtaining a relationship between the radiation and a wavelength; 5) finding at least 3 bands with a least gas absorption rate; 6) calculating a distance between a wavelength of a strongest radiation point of the turbine blade and the center wavelength, and selecting three central wavelengths closest to the wavelength with the strongest radiation; and 7) acquiring radiation data of the turbine blade in the windows obtained in 6).
    Type: Grant
    Filed: January 14, 2018
    Date of Patent: June 2, 2020
    Assignee: UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA
    Inventors: Chao Wang, Ying Duan, Jun Hu, Zezhan Zhang, Yang Yang, Xueke Gou, Fei Wang, Jing Jiang, Jinguang Lv, Yueming Wang, Hongchuan Jiang, Li Du, Jiexiong Ding, Jingqiu Liang, Xianfu Liu, Xiaojiang Shi, Bing Xiong
  • Publication number: 20200031802
    Abstract: The present invention relates to dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof. The inhibitor of the present invention is compound represented by general formula (I), or stereoisomer, pharmaceutically acceptable salt, prodrug, solvate, hydrate and crystal form thereof. The definition of each substituent is as described in the description and claims. The compound represented by general formula (I) of the present invention may inhibit bromodomain recognition protein and may be used for preparing medicament which regulates the apparent state of cells and treats series of diseases and symptoms which are mediated by the bromodomain recognition protein.
    Type: Application
    Filed: March 5, 2018
    Publication date: January 30, 2020
    Inventors: Bing XIONG, Jingkang SHEN, Zehong MIAO, Jianping HU, Yingqing WANG, Shanshan SONG, Tao MENG
  • Publication number: 20190003893
    Abstract: A method of collecting radiation information of a turbine blade, the method including: 1) collecting a radiated light from the surface of the turbine blade, analyzing the radiated light using a spectrometer to calculate compositions and corresponding concentrations of combustion gas; 2) calculating an absorption coefficient of the combustion gas at different concentrations; 3) calculating a total absorption rate of the combustion gas at different radiation wavelengths under different concentrations of component gases; 4) obtaining a relationship between the radiation and a wavelength; 5) finding at least 3 bands with a least gas absorption rate; 6) calculating a distance between a wavelength of a strongest radiation point of the turbine blade and the center wavelength, and selecting three central wavelengths closest to the wavelength with the strongest radiation; and 7) acquiring radiation data of the turbine blade in the windows obtained in 6).
    Type: Application
    Filed: January 14, 2018
    Publication date: January 3, 2019
    Inventors: Chao WANG, Ying DUAN, Jun HU, Zezhan ZHANG, Yang YANG, Xueke GOU, Fei WANG, Jing JIANG, Jinguang LV, Yueming WANG, Hongchuan JIANG, Li DU, Jiexiong DING, Jingqiu LIANG, Xianfu LIU, Xiaojiang SHI, Bing XIONG
  • Patent number: 9988381
    Abstract: This invention provides a class of five-member-heterocycle fused pyridine compounds as shown below in Formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a method of producing the same, pharmaceutical compositions containing the compound, and use of the compounds in preparing medicament for preventing and/or treating diseases and tumors associated with abnormal protein tyrosine kinase.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: June 5, 2018
    Assignees: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai Haihe Pharmaceutical Co., Ltd.
    Inventors: Jingkang Shen, Meiyu Geng, Jian Ding, Bing Xiong, Jing Al, Yuchi Ma, Xin Wang, Xia Peng, Yuelei Chen, Danqi Chen, Tao Meng, Lanping Ma, Yinchun Ji
  • Publication number: 20160137640
    Abstract: This invention provides a class of five-member-heterocycle fused pyridine compounds as shown below in Formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a method of producing the same, pharmaceutical compositions containing the compound, and use of the compounds in preparing medicament for preventing and/or treating diseases and tumours associated with abnormal protein tyrosine kinase.
    Type: Application
    Filed: June 18, 2014
    Publication date: May 19, 2016
    Inventors: Jingkang Shen, Meiyu Geng, Jian Ding, Bing Xiong, Jing Al, Yuchi Ma, Xin Wang, Xia Peng, Yuelei Chen, Danqi Chen, Tao Meng, Lanping Ma, Yinchun Ji
  • Publication number: 20100137206
    Abstract: This application relates to micelle-forming poly(ethylene oxide)-block-poly(ester) block copolymers having reactive groups on both the poly(ethylene oxide) block and the poly(ester) block therein. The biodegradability of these copolymers and their biocompatibilities with a large number of bioactive agents make them suitable as carriers for various bioactive agents. The bioactive agent, such as DNA, RNA, oligonucleotide, protein, peptide, drug and the like, can be coupled to the reactive groups on the polyester block of the copolymer. A variety of targeting moieties can be coupled to the reactive group on the poly(ethylene oxide) block for targeting the bioactive agent to a particular tissue. The application also relates to a composition and method of use thereof for delivering bioactive agents.
    Type: Application
    Filed: December 17, 2007
    Publication date: June 3, 2010
    Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    Inventors: Afsaneh Lavasanifar, Xiao-Bing Xiong
  • Patent number: 7662860
    Abstract: The present invention discloses 3D-structure of SARS-CoV Viral 3CL Protease obtained through molecular simulation. The 3D-structure is used as a drug target for screening the existing medical database CMC (Comprehensive Medicinal Chemistry, MDL Information System, Inc.), and a group of compounds which have the activity of inhibiting SARS-CoV virus 3CL Protease are found. Cinanserin was tested at molecular and viral levels, and it was found to be able to inhibit the SARS-CoV viral 3CL protease and SARS-CoV viruses. Cinanserin analogs were synthesized and tested at molecular and viral levels, they were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: February 16, 2010
    Assignees: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai Lead Discovery Pharmaceuticals Limited Company
    Inventors: Jianhua Shen, Hualiang Jiang, Xu Shen, Jianping Zuo, Xiaomin Luo, Donglu Bai, Jingkang Shen, Kaixian Chen, Chunshan Gui, Lili Chen, Jing Chen, Yifu Yang, Xianhan Zhuang, Yiming Yang, Xuchang He, Hong Liu, Bing Xiong, Haibin Luo, Tao Sun, Fei Ye
  • Patent number: 7519080
    Abstract: A technique for providing multiple Fiber Channel frames in one frame-mapped GFP transport frame. GFP conventions are followed, except that a Distributed Delimiter marks each Fiber Channel frame in the payload of GFP transport frame. The Distributed Delimiter has a Fixed Pattern field which varies distinctly from the special K28.5 character which indicates Fiber Channel Ordered Sets and has a Frame Length field to indicate the length of the Fiber Channel frame.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: April 14, 2009
    Assignee: Cisco Technology, Inc.
    Inventors: Bing Xiong, Fan Zhou
  • Publication number: 20070127526
    Abstract: A technique for providing multiple Fibre Channel frames in one frame-mapped GFP transport frame. GFP conventions are followed, except that a Distributed Delimiter marks each Fibre Channel frame in the payload of GFP transport frame. The Distributed Delimiter has a Fixed Pattern field which varies distinctly from the special K28.5 character which indicates Fibre Channel Ordered Sets and has a Frame Length field to indicate the length of the Fibre Channel frame.
    Type: Application
    Filed: January 22, 2007
    Publication date: June 7, 2007
    Applicant: CISCO TECHNOLOGY, INC.
    Inventors: Bing Xiong, Fan Zhou
  • Patent number: 7187650
    Abstract: A technique for providing multiple Fibre Channel frames in one frame-mapped GFP transport frame. GFP conventions are followed, except that a Distributed Delimiter marks each Fibre Channel frame in the payload of GFP transport frame. The Distributed Delimiter has a Fixed Pattern field which varies distinctly from the special K28.5 character which indicates Fibre Channel Ordered Sets and has a Frame Length field to indicate the length of the Fibre Channel frame.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: March 6, 2007
    Assignee: Cisco Technology, Inc.
    Inventors: Bing Xiong, Fan Zhou
  • Publication number: 20060142383
    Abstract: The present invention discloses 3D-structure of SARS-CoV Viral 3CL Protease obtained through molecular simulation. The 3D-structure is used as a drug target for screening the existing medical database CMC (Comprehensive Medicinal Chemistry, MDL Information System, Inc.), and a group of compounds which have the activity of inhibiting SARS-CoV virus 3CL Protease are found. Cinanserin was tested at molecular and viral levels, and it was found to be able to inhibit the SARS-CoV viral 3CL protease and SARS-CoV viruses. Cinanserin analogs were synthesized and tested at molecular and viral levels, they were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection.
    Type: Application
    Filed: December 2, 2005
    Publication date: June 29, 2006
    Inventors: Jianhua Shen, Hualiang Jiang, Xu Shen, Jianping Zuo, Xiaomin Luo, Donglu Bai, Jingkang Shen, Kaixian Chen, Chunshan Gui, Lili Chen, Jing Chen, Yifu Yang, Xianhan Zhuang, Yiming Yang, Xuchang He, Hong Liu, Bing Xiong, Haibin Luo, Tao Sun, Fei Ye
  • Publication number: 20040252720
    Abstract: A technique for providing multiple Fibre Channel frames in one frame-mapped GFP transport frame. GFP conventions are followed, except that a Distributed Delimiter marks each Fibre Channel frame in the payload of GFP transport frame. The Distributed Delimiter has a Fixed Pattern field which varies distinctly from the special K28.5 character which indicates Fibre Channel Ordered Sets and has a Frame Length field to indicate the length of the Fibre Channel frame.
    Type: Application
    Filed: June 10, 2003
    Publication date: December 16, 2004
    Applicant: CISCO TECHNOLOGY, INC.
    Inventors: Bing Xiong, Fan Zhou